Heimo Ehmke

Title: Heimo Ehmke: Innovator in Rho Kinase Inhibitors

Introduction

Heimo Ehmke is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target Rho kinase. With a total of 3 patents to his name, Ehmke's work has the potential to impact the treatment of cardiovascular disorders.

Latest Patents

Ehmke's latest patents include innovative compounds such as hetaryloxy-substituted phenylamino pyrimidines and heteroaryloxy-substituted phenylaminopyrimidines. These inventions focus on the inhibition of Rho kinase, which plays a crucial role in various diseases. The first patent describes the use of these compounds for preparing medicaments aimed at treating and preventing cardiovascular disorders in both humans and animals. The second patent further explores the production methods and applications of these compounds in the medical field.

Career Highlights

Throughout his career, Heimo Ehmke has worked with prominent companies in the pharmaceutical industry, including Bayer Schering Pharma AG and Bayer Intellectual Property GmbH. His experience in these organizations has allowed him to refine his expertise in drug development and patenting.

Collaborations

Ehmke has collaborated with notable colleagues such as Samir Bennabi and Hartmut Schirok. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Heimo Ehmke's innovative work in the field of Rho kinase inhibitors showcases his dedication to advancing medical science. His contributions have the potential to lead to significant improvements in the treatment of cardiovascular diseases.